Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 2/20 | 0.64 |
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.41 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3776510 | 1.00 | ARG1 (0.64) | ARG1DPP4CYP1A2ALOX15CYP2C19 | |
| SCHEMBL26118062 | 1.00 | ARG1 (0.64) | ARG1DPP4CYP1A2ALOX15CYP2C19 | |
| SCHEMBL11650754 | 1.00 | ARG1 (0.64) | ARG1DPP4CYP1A2ALOX15CYP2C19 | |
| SCHEMBL5511790 | 0.89 | ARG1 (0.60) | ARG1DPP4CYP1A2ALOX15CYP2C19 | |
| SCHEMBL3787271 | 0.89 | ARG1 (0.60) | ARG1DPP4CYP1A2ALOX15CYP2C19 | |
| SCHEMBL4867875 | 0.87 | ARG1 (0.58) | ARG1DPP4CYP1A2ALOX15CYP2C19 | |
| SCHEMBL3780786 | 0.87 | ARG1 (0.58) | ARG1DPP4CYP1A2ALOX15CYP2C19 | |
| SCHEMBL7442641 | 0.84 | ARG1 (0.58) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL7411388 | 0.84 | ARG1 (0.58) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 | |
| SCHEMBL3781411 | 0.84 | ARG1 (0.58) | ARG1CYP1A2ALOX15CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11390662-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-07-19 | — | — | US | claimed |
| US-10329341-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-06-25 | — | — | US | claimed |
| US-20180030115-A1 | COLLAGEN MIMICS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-02-01 | — | — | US | claimed |
| US-9758569-B2 | Collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-09-12 | — | — | US | claimed |
| WO-2010127645-A2 | THE METHOD OF BIOTECHNOLOGICAL PREPARATION OF LINCOMYCIN DERIVATIVES AND ITS USING | INSTITUTE OF MICROBIOLOGY AS CR, V. V. I. (CZ) | 2010-11-11 | — | — | WO | claimed |
| WO-2007139914-A2 | COLLAGEN MIMICS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2007-12-06 | — | — | WO | claimed |
| US-20070275897-A1 | Collagen mimics | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-11-29 | — | — | US | claimed |
| CN-117987496-A | Fermentation method for reducing lincomycin B component | 宁夏泰益欣生物科技股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117305288-A | EcTyrA protein mutant and application thereof in improving L-tyrosine yield | 河南省健康元生物医药研究院有限公司 | 2023-12-29 | — | — | CN | disclosed |
| WO-2010127645-A3 | THE METHOD OF BIOTECHNOLOGICAL PREPARATION OF LINCOMYCIN DERIVATIVES AND ITS USING | INSTITUTE OF MICROBIOLOGY AS CR, V. V. I. (CZ) | 2011-01-20 | — | — | WO | disclosed |
| US-7858741-B2 | Stabilization of the collagen triple helix by O-methylation of hydroxyproline residues | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-12-28 | — | — | US | disclosed |
| WO-2010127645-A2 | THE METHOD OF BIOTECHNOLOGICAL PREPARATION OF LINCOMYCIN DERIVATIVES AND ITS USING | INSTITUTE OF MICROBIOLOGY AS CR, V. V. I. (CZ) | 2010-11-11 | — | — | WO | disclosed |
| WO-2010127645-A2 | THE METHOD OF BIOTECHNOLOGICAL PREPARATION OF LINCOMYCIN DERIVATIVES AND ITS USING | INSTITUTE OF MICROBIOLOGY AS CR, V. V. I. (CZ) | 2010-11-11 | — | — | WO | disclosed |
| US-20090264626-A1 | STABILIZATION OF THE COLLAGEN TRIPLE HELIX BY O-METHYLATION OF HYDROXYPROLINE RESIDUES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-10-22 | — | — | US | disclosed |
| WO-2009100360-A1 | STABILIZATION OF THE COLLAGEN TRIPLE HELIX BY O-METHYLATION OF HYDROXYPROLINE RESIDUES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-08-13 | — | — | WO | disclosed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | disclosed |
| EP-0048159-A2 | Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents | UNIVERSITY OF MIAMI (US) | 1982-03-24 | — | — | EP | disclosed |
| US-RE29558-E | Lincomycin analogs | THE UPJOHN COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264626-A1 | STABILIZATION OF THE COLLAGEN TRIPLE HELIX BY O-METHYLATION OF HYDROXYPROLINE RESIDUES | COL14A1, COL2A1, PLOD3 | ARG1 67/4885DPP4 1346/4885CYP1A2 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.